This patient survived a dozen tumors. Here’s what we can learn from their unique immune system

Credit: Op-Med
Credit: Op-Med

A unique patient who has survived the development of a dozen tumors could hold the key to curing cancer, a new study reveals.

Their review found that the individual is “programmed” to develop different forms of the disease after inheriting mutations in a gene from both parents. However, their immune system naturally generates a strong anti-inflammatory response that fights the growths. Knowing how it does this offers a “groundbreaking” hope of earlier disease diagnosis and new immunotherapy drugs.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

The unnamed patient around the age of 40 has had 12 tumors, with at least five of them being malignant. The first developed during infancy, followed by others every few years. Each has been of a different type and in a different part of the body. The patient also has skin spots, the birth defect microcephaly which causes a smaller head and brain, and other alterations.

According to Malumbres, the study of this unique case opens up “a way to detect cells with tumor potential well in advance of clinical tests and diagnostic imaging. It also provides a novel way to stimulate the immune response to a cancerous process.”

This is an excerpt. Read the full article here

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1
Hiroshima at 81: America’s new nuclear bomb, a buried Iranian target, and a question no one wants to ask
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
png livestock cow cattle a
Consumer skepticism about gene-edited milk is neither fixed nor particularly high—and falls even more if it’s priced lower
ChatGPT-Image-Aug-4-2026-10_15_14-AM
Viewpoint—A hard look at the Fauci diaries: Do they change what we know about COVID’s origins?
ChatGPT-Image-Jul-31-2026-07_35_35-AM
Wikipedia has assembled an informative list of fake news websites from across the ideological spectrum
Screenshot-2026-07-31-at-10.52.03-AM
Love sweets and fatty foods? You can blame your genes, but there are ways to quell the obsessions
Screenshot-2026-08-03-at-2.25.49-PM
As measles vaccination rates collapse, scientists push for treatments long considered unnecessary
ChatGPT Image Jul 29, 2026, 09_08_15 AM 2
The retreat of environmental extremism: Why activist NGOs are losing favor
Screenshot-2026-08-03-at-2.15.16-PM
Viewpoint: Trump’s relaxed controls on supplying China with microchips could undermine U.S. AI dominance
Screenshot-2026-07-17-at-1.34.59-PM
Poll: Vaccine hesitancy soars when patients distrust health providers and turn to social media
ChatGPT Image Jul 29, 2026, 10_17_59 AM
Viewpoint: What does it mean when critics of conventional agriculture say many fruits and vegetables are “linked” to pesticide poisoning?
ChatGPT-Image-Aug-4-2026-09_31_50-AM-2
Viewpoint: Could the U.S. become dependent on China to develop critical new genetic and drug therapies?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.